Chronic StrokeNCT04947293
Yoga Among Stroke Patients With Chronic Sequelae
A study testing Physical activity in people with Chronic Stroke, run by Hopital La Musse at 3 sites in France.
Trial summary
Stroke is a major health problem and can cause long-term disability. Among these sequelae, there are balance and mobility disorders, but also a higher rate of anxiety or depression disorders. This impairments impact activity of daily living, and social reintegration. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Chronic Stroke
- What is being tested?
- Physical activity
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 3 sitesFrance
- Study dates
- 21 Aug 2021to 30 Sep 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- a minimum of six month elapsed time since stroke incidence
- present balance disorders (score between 21 and 51 on the Berg Balance Scale)
- ability to stand and walk at least 10 metres (with or without an assistance device)
- be affiliated to a social security system
Who cannot join
- under 18 years of age
- cognitive impairment assessed by a score of less than 4 on the 6-items Mini-Mental State Examination
- inability to understand the French language (to the point of not being able to answer questionnaires, or understand instruction)
- medical contraindication to the practice of a sport activity
- current and regular participation in a physical activity program
- Being deprived of liberty by a judicial or administrative decision,
Show all 9Show fewer
- Receive psychiatric care,
- Be subject to a legal protection measure (guardianship, curatorship and safeguarding of justice),
- Being a pregnant, parturient or breastfeeding woman
Trial locations and contacts
3 sites in 1 country.
France3 sites
City hall of Broglie
Broglie, Eure, 27270
City Hall of Corneville sur Risle
Corneville-sur-Risle, 27500
Hopital La Musse
Saint-Sébastien-de-Morsent, 27180
About this study
Official title: Effects of Yoga in the Rehabilitation of Stroke Patients With Chronic Sequelea: A Randomized Controlled Trial.
Stroke is a major health problem and can cause long-term disability. Among these sequelae, there are balance and mobility disorders, but also a higher rate of anxiety or depression disorders. This impairments impact activity of daily living, and social reintegration. That why the investigators need to explore options for long-term sustainable interventions that which takes into account the patient as a whole. In particular, regular physical activity is recommended, but it must be adaptable to the patient's impairments. Teaching yoga may be an interesting option. Indeed, yoga is a mind-body practice which become increasingly widespread in the world. Recent studies highlight positive effect of yoga for this population. However, the levels of evidence are limited, and new studies are needed.
Primary objective of the study is to demonstrate the non-inferiority of a therapeutic yoga program, compared to a conventional physical activity program, to improve balance of patients with chronic stroke sequelae.
Secondary objectives are to demonstrate the non-inferiority of the therapeutic yoga program in improving muscle strength and functional mobility, as well as its superiority in improving anxiety, depression, social reintegration and adherence to treatment.
Read the detailed description
The investigators will conduct a single-blind randomised controlled trial to study the effectiveness of a yoga programme compared to a conventional adapted physical activity programme in improving balance in chronic post-stroke subjects. The primary hypothesis is that yoga is non-inferior to conventional physical activity in improving balance in chronic post-stroke patients. The secondary hypothesis is that yoga is non-inferior to conventional physical activity in improving muscle strength and functional mobility, but superior in improving anxiety, depression, social reintegration and treatment adherence.
The experiment will take place in Normandy (France), at several sites in order to maximise recruitment and minimise travel for participants. The statistical power study indicates that 42 patients per group would be required. Subjects will be randomly assigned to one of the following programmes: the YOG'AVC programme or the FAME programme. The first will involve yoga sessions with postural, respiratory, and meditative work. The second will involve more conventional exercise sessions, based on a Fitness and Mobility Exercise Program (FAME) designed for stroke survivors. Both programmes included two 60-minute group sessions per week, for 12 weeks, plus one weekly home-based session (with video or paper support). Patients will be assessed at three points in the study: before the experiment (T0), after the 12-week experiment (T1), and 3 months later (T2). The assessments will be carried out blind, using a protocol built around the International Classification of Functioning and Disability (ICF). The main criterion is balance, assessed by the Berg balance scale (0-56 point scale). The secondary outcomes will be assessed by: Timed Up and Go Test (timed task in seconds), 6-minute walk test (distance covered in meters), maximum isometric knee extension force with a manual dynamometer (newton), the activities-specific Balance Confidence Scale - Simplified (questionnaire in %), State-Trait Anxiety Inventory (2 questionnaires out of 80), Beck Depression Inventory (score out of 63), Reintegration to Normal Living Index (score out of 100). Adherence to the programme will be assessed by a logbook, between T0 and T1 by the number of group and individual sessions completed, and between T1 and T2 by the number of self-reported sessions.
- Conditions
- Chronic Stroke
- Being tested
- Physical activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Physical activityOther
Both groups will practice a physical activity adapted to their motor skills. They will have two group sessions (maximum 5 people per group) in a face-to-face setting, and one independent session at home supported by a video, each week. These programs last 12 weeks, and will be supervised by the same person, a physiotherapist.
| Study group | Role | What they receive |
|---|---|---|
| Yoga Exercise | Experimental | Subjects in the experimental group will be invited to participate in 60-minute yoga sessions twice a week for 12 weeks. Each session will include postural (asanas), breathing (pranayama), and meditative exercises. They will be adapted to the physical possibilities of the patients with the help of accessories such as chairs, straps, blankets, blocks. One additional session (60 minutes) per week, in autonomy, at home, will be recommended and accompanied by a video support. Receives: Other: Physical activity |
| Fitness and mobility exercise | Active comparator | Subjects in the control group will be invited to participate in more conventional exercise sessions, based on a fitness and mobility exercise (FAME) program, 60-minute per sessions twice a week for 12 weeks. One additional session (60 minutes) per week, in autonomy, at home, will be recommended and accompanied by a video support. The effectiveness of this program has already been demonstrated in previous studies. Receives: Other: Physical activity |
What is being measured
The primary outcome is the main question the study is designed to answer.
Functional Balance
Berg Balance Scale : This test is used to quantitatively assess balance in older adults. In this 14-item scale, patients are asked to maintain positions and perform movement tasks of varying degrees of difficulty. Patients receive a score between 0 and 4 on their ability to respond to dimensions of balance. An overall score can be calculated from a total of 56. The higher the score, the better the balance. This scale has been found to be reliable, valid, and is the most commonly used clinical and research scale for assessing balance in stroke patients.
Measured: Baseline
Functional Balance
Berg Balance Scale : This test is used to quantitatively assess balance in older adults. In this 14-item scale, patients are asked to maintain positions and perform movement tasks of varying degrees of difficulty. Patients receive a score between 0 and 4 on their ability to respond to dimensions of balance. An overall score can be calculated from a total of 56. The higher the score, the better the balance. This scale has been found to be reliable, valid, and is the most commonly used clinical and research scale for assessing balance in stroke patients.
Measured: Immediately after the intervention
Functional Balance
Berg Balance Scale : This test is used to quantitatively assess balance in older adults. In this 14-item scale, patients are asked to maintain positions and perform movement tasks of varying degrees of difficulty. Patients receive a score between 0 and 4 on their ability to respond to dimensions of balance. An overall score can be calculated from a total of 56. The higher the score, the better the balance. This scale has been found to be reliable, valid, and is the most commonly used clinical and research scale for assessing balance in stroke patients.
Measured: 3 months follow-up
Secondary outcomes (23)
Functional mobility
Timed Up and Go Test : It is a test based on the performance of a functional task, where the subject must get up from a chair, walk 3 meters, turn around and return to a seat. The subject is timed during the execution and a score in seconds is established. The reliability and validity of this test was established in a chronic stroke population.
Measured: Baseline
Functional mobility
Timed Up and Go Test : It is a test based on the performance of a functional task, where the subject must get up from a chair, walk 3 meters, turn around and return to a seat. The subject is timed during the execution and a score in seconds is established. The reliability and validity of this test was established in a chronic stroke population.
Measured: Immediately after the intervention
Functional mobility
Timed Up and Go Test : It is a test based on the performance of a functional task, where the subject must get up from a chair, walk 3 meters, turn around and return to a seat. The subject is timed during the execution and a score in seconds is established. The reliability and validity of this test was established in a chronic stroke population.
Measured: 3 months follow-up
Gait performance
The 6-minute walk test (TDM6) : an endurance test where the subject must walk for 6 minutes over the longest possible distance (score in meters). This test is reliable and valid for a chronic stroke population.
Measured: Baseline
Gait performance
The 6-minute walk test (TDM6) : an endurance test where the subject must walk for 6 minutes over the longest possible distance (score in meters). This test is reliable and valid for a chronic stroke population.
Measured: Immediately after the intervention
Gait performance
The 6-minute walk test (TDM6) : an endurance test where the subject must walk for 6 minutes over the longest possible distance (score in meters). This test is reliable and valid for a chronic stroke population.
Measured: 3 months follow-up
Maximum isometric muscle strength of the knee extensors
Manual dynamometer (Microfet2®). Subject is seated, knees and hips bent at 90°. The dynamometer is placed on the anterior surface of the tibia, 5 cm from the malleoli, with a tip adapted to the surface being tested. The subject is invited to push against the resistance, as if stretching the leg, with all the force he or she can muster. The measurement is repeated 3 times, and the score (in Newton) is established by averaging the 3 trials. Hand-held dynamometry is a reliable and valid method for assessing muscle strength in a stroke population.
Measured: Baseline
Maximum isometric muscle strength of the knee extensors
Manual dynamometer (Microfet2®). Subject is seated, knees and hips bent at 90°. The dynamometer is placed on the anterior surface of the tibia, 5 cm from the malleoli, with a tip adapted to the surface being tested. The subject is invited to push against the resistance, as if stretching the leg, with all the force he or she can muster. The measurement is repeated 3 times, and the score (in Newton) is established by averaging the 3 trials. Hand-held dynamometry is a reliable and valid method for assessing muscle strength in a stroke population.
Measured: Immediately after the intervention
Maximum isometric muscle strength of the knee extensors
Manual dynamometer (Microfet2®). Subject is seated, knees and hips bent at 90°. The dynamometer is placed on the anterior surface of the tibia, 5 cm from the malleoli, with a tip adapted to the surface being tested. The subject is invited to push against the resistance, as if stretching the leg, with all the force he or she can muster. The measurement is repeated 3 times, and the score (in Newton) is established by averaging the 3 trials. Hand-held dynamometry is a reliable and valid method for assessing muscle strength in a stroke population.
Measured: 3 months follow-up
Activities-specific Balance Confidence Scale - Simplified
This questionnaire consists of 16 questions that require the patient to assess his or her confidence that he or she will not lose balance while performing the cited activities. For each of the 16 activities, the patient is asked to rate their confidence from 0 (not at all confident) to 3 (very confident). The total score is given as a percentage. The reliability and validity of the French version of this questionnaire has been established.
Measured: Baseline
Activities-specific Balance Confidence Scale - Simplified
This questionnaire consists of 16 questions that require the patient to assess his or her confidence that he or she will not lose balance while performing the cited activities. For each of the 16 activities, the patient is asked to rate their confidence from 0 (not at all confident) to 3 (very confident). The total score is given as a percentage. The reliability and validity of the French version of this questionnaire has been established.
Measured: Immediately after the intervention
Activities-specific Balance Confidence Scale - Simplified
This questionnaire consists of 16 questions that require the patient to assess his or her confidence that he or she will not lose balance while performing the cited activities. For each of the 16 activities, the patient is asked to rate their confidence from 0 (not at all confident) to 3 (very confident). The total score is given as a percentage. The reliability and validity of the French version of this questionnaire has been established.
Measured: 3 months follow-up
State Trait Anxiety Inventory
The 2 forms of the State Trait Anxiety Inventory (STAI, Form Y) will use to measure state anxiety (STAI-Y1) and trait anxiety (STAI-Y2).
The 2 forms consist of 20 items each, which are rated on a 4-point Likert-type scale depending on how the participant feels at the moment in time for STAI-Y1 or how the participant feels generally for STAI-Y2. Higher scores are associated with increased symptoms of state or trait anxiety.
Measured: Baseline
State Trait Anxiety Inventory
The 2 forms of the State Trait Anxiety Inventory (STAI, Form Y) will use to measure state anxiety (STAI-Y1) and trait anxiety (STAI-Y2).
The 2 forms consist of 20 items each, which are rated on a 4-point Likert-type scale depending on how the participant feels at the moment in time for STAI-Y1 or how the participant feels generally for STAI-Y2. Higher scores are associated with increased symptoms of state or trait anxiety.
Measured: Immediately after the intervention
State Trait Anxiety Inventory
The 2 forms of the State Trait Anxiety Inventory (STAI, Form Y) will use to measure state anxiety (STAI-Y1) and trait anxiety (STAI-Y2).
The 2 forms consist of 20 items each, which are rated on a 4-point Likert-type scale depending on how the participant feels at the moment in time for STAI-Y1 or how the participant feels generally for STAI-Y2. Higher scores are associated with increased symptoms of state or trait anxiety.
Measured: 3 months follow-up
Beck Depression Inventory
This self-questionnaire includes 21 items identifying symptoms and attitudes associated with depression. Each item is assessed on a severity scale ranging from 0 to 3, with a total score ranging from 0 to 63.The higher the score, the more severe the depression. The reliability and validity of the French version of this questionnaire has been established.
Measured: Baseline
Beck Depression Inventory
This self-questionnaire includes 21 items identifying symptoms and attitudes associated with depression. Each item is assessed on a severity scale ranging from 0 to 3, with a total score ranging from 0 to 63.The higher the score, the more severe the depression. The reliability and validity of the French version of this questionnaire has been established.
Measured: Immediately after the intervention
Beck Depression Inventory
This self-questionnaire includes 21 items identifying symptoms and attitudes associated with depression. Each item is assessed on a severity scale ranging from 0 to 3, with a total score ranging from 0 to 63.The higher the score, the more severe the depression. The reliability and validity of the French version of this questionnaire has been established.
Measured: 3 months follow-up
Reintegration to Normal Living Index
This self-questionnaire was developed to quantitatively assess the degree to which individuals who have experienced a traumatic or disabling illness are able to reintegrate into normal social activities (e.g., recreational activities, movement in the community, and interactions with family and other relationships). It is composed of 11 declarative statements (e.g. I move around my home as much as I want), and the patient gives a score between 0 and 2 (yes, partially, no). The total score is between 0 and 22 points, a high score indicates low reintegration.
Measured: Baseline
Reintegration to Normal Living Index
This self-questionnaire was developed to quantitatively assess the degree to which individuals who have experienced a traumatic or disabling illness are able to reintegrate into normal social activities (e.g., recreational activities, movement in the community, and interactions with family and other relationships). It is composed of 11 declarative statements (e.g. I move around my home as much as I want), and the patient gives a score between 0 and 2 (yes, partially, no). The total score is between 0 and 22 points, a high score indicates low reintegration.
Measured: Immediately after the intervention
Reintegration to Normal Living Index
This self-questionnaire was developed to quantitatively assess the degree to which individuals who have experienced a traumatic or disabling illness are able to reintegrate into normal social activities (e.g., recreational activities, movement in the community, and interactions with family and other relationships). It is composed of 11 declarative statements (e.g. I move around my home as much as I want), and the patient gives a score between 0 and 2 (yes, partially, no). The total score is between 0 and 22 points, a high score indicates low reintegration.
Measured: 3 months follow-up
Compliance during the program
A percentage will be established according to the number of sessions actually performed compared to the number of planned sessions.
Measured: During the intervention
Compliance after the program
A percentage will be established based on the number of sessions actually completed compared to the number of sessions recommended.
Measured: 3 months follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Jul 2021
- Study start21 Aug 2021
- Primary completion30 Sep 2022
- Study completion30 Sep 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Chronic StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 36 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hopital La Musse
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Maxime Gilliaux, PhD, Principal investigator, Hôpital La Musse
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04947293
- Sponsor's protocol ID
- 2020-A03408-31
- Status last verified
- Mar 2023
- First submitted
- 11 Jun 2021
- Last updated
- 9 Mar 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The data collected will be anonymized, computerized and stored by Maxime GILLIAUX. Only the investigators will have access to the anonymized data in order to carry out the statistical work of this research.
Publications
Green E, Huynh A, Broussard L, Zunker B, Matthews J, Hilton CL, Aranha K. Systematic Review of Yoga and Balance: Effect on Adults With Neuromuscular Impairment. Am J Occup Ther. 2019 Jan/Feb;73(1):7301205150p1-7301205150p11. doi: 10.5014/ajot.2019.028944.
PubMed 30839270Thayabaranathan T, Andrew NE, Immink MA, Hillier S, Stevens P, Stolwyk R, Kilkenny M, Cadilhac DA. Determining the potential benefits of yoga in chronic stroke care: a systematic review and meta-analysis. Top Stroke Rehabil. 2017 May;24(4):279-287. doi: 10.1080/10749357.2016.1277481. Epub 2017 Jan 19.
PubMed 28100160Edwards MK, Loprinzi PD. Comparative effects of meditation and exercise on physical and psychosocial health outcomes: a review of randomized controlled trials. Postgrad Med. 2018 Mar;130(2):222-228. doi: 10.1080/00325481.2018.1409049. Epub 2017 Nov 27.
PubMed 29164993
Study at a glance
From the registry record, last updated by the sponsor on 9 Mar 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Yoga in the Rehabilitation of Stroke Patients With Chronic Sequelea: A Randomized Controlled Trial.
- ClinicalTrials.gov ID
- NCT04947293
- Acronym / sponsor ID
- 2020-A03408-31
- Conditions
- Chronic Stroke
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 36 participants (actual)
- Lead sponsor
- Hopital La MusseUniversity, hospital or other
- Study start
- 21 Aug 2021 (actual)
- Primary completion
- 30 Sep 2022 (actual)
- Study completion
- 30 Sep 2022 (actual)
- First posted
- 1 Jul 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Stroke is a major health problem and can cause long-term disability. Among these sequelae, there are balance and mobility disorders, but also a higher rate of anxiety or depression disorders. This impairments impact activity of daily living, and social reintegration. That why the investigators need to explore options for long-term sustainable interventions that which takes into account the patient as a whole. In particular, regular physical activity is recommended, but it must be adaptable to the patient's impairments. Teaching yoga may be an interesting option. Indeed, yoga is a mind-body practice which become increasingly widespread in the world. Recent studies highlight positive effect of yoga for this population. However, the levels of evidence are limited, and new studies are needed.
Primary objective of the study is to demonstrate the non-inferiority of a therapeutic yoga program, compared to a conventional physical activity program, to improve balance of patients with chronic stroke sequelae.
Secondary objectives are to demonstrate the non-inferiority of the therapeutic yoga program in improving muscle strength and functional mobility, as well as its superiority in improving anxiety, depression, social reintegration and adherence to treatment.
Detailed description
The investigators will conduct a single-blind randomised controlled trial to study the effectiveness of a yoga programme compared to a conventional adapted physical activity programme in improving balance in chronic post-stroke subjects. The primary hypothesis is that yoga is non-inferior to conventional physical activity in improving balance in chronic post-stroke patients. The secondary hypothesis is that yoga is non-inferior to conventional physical activity in improving muscle strength and functional mobility, but superior in improving anxiety, depression, social reintegration and treatment adherence.
The experiment will take place in Normandy (France), at several sites in order to maximise recruitment and minimise travel for participants. The statistical power study indicates that 42 patients per group would be required. Subjects will be randomly assigned to one of the following programmes: the YOG'AVC programme or the FAME programme. The first will involve yoga sessions with postural, respiratory, and meditative work. The second will involve more conventional exercise sessions, based on a Fitness and Mobility Exercise Program (FAME) designed for stroke survivors. Both programmes included two 60-minute group sessions per week, for 12 weeks, plus one weekly home-based session (with video or paper support). Patients will be assessed at three points in the study: before the experiment (T0), after the 12-week experiment (T1), and 3 months later (T2). The assessments will be carried out blind, using a protocol built around the International Classification of Functioning and Disability (ICF). The main criterion is balance, assessed by the Berg balance scale (0-56 point scale). The secondary outcomes will be assessed by: Timed Up and Go Test (timed task in seconds), 6-minute walk test (distance covered in meters), maximum isometric knee extension force with a manual dynamometer (newton), the activities-specific Balance Confidence Scale - Simplified (questionnaire in %), State-Trait Anxiety Inventory (2 questionnaires out of 80), Beck Depression Inventory (score out of 63), Reintegration to Normal Living Index (score out of 100). Adherence to the programme will be assessed by a logbook, between T0 and T1 by the number of group and individual sessions completed, and between T1 and T2 by the number of self-reported sessions.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Yoga Exercise | Experimental | Other: Physical activitySubjects in the experimental group will be invited to participate in 60-minute yoga sessions twice a week for 12 weeks. Each session will include postural (asanas), breathing (pranayama), and meditative exercises. They will be adapted to the physical possibilities of the patients with the help of accessories such as chairs, straps, blankets, blocks. One additional session (60 minutes) per week, in autonomy, at home, will be recommended and accompanied by a video support. |
| Fitness and mobility exercise | Active comparator | Other: Physical activitySubjects in the control group will be invited to participate in more conventional exercise sessions, based on a fitness and mobility exercise (FAME) program, 60-minute per sessions twice a week for 12 weeks. One additional session (60 minutes) per week, in autonomy, at home, will be recommended and accompanied by a video support. The effectiveness of this program has already been demonstrated in previous studies. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- a minimum of six month elapsed time since stroke incidence
- present balance disorders (score between 21 and 51 on the Berg Balance Scale)
- ability to stand and walk at least 10 metres (with or without an assistance device)
- be affiliated to a social security system
Key exclusion criteria (9 listed)
- under 18 years of age
- cognitive impairment assessed by a score of less than 4 on the 6-items Mini-Mental State Examination
- inability to understand the French language (to the point of not being able to answer questionnaires, or understand instruction)
- medical contraindication to the practice of a sport activity
- current and regular participation in a physical activity program
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Physical activityBoth groups will practice a physical activity adapted to their motor skills. They will have two group sessions (maximum 5 people per group) in a face-to-face setting, and one independent session at home supported by a video, each week. These programs last 12 weeks, and will be supervised by the same person, a physiotherapist. | Other | Fitness and mobility exercise, Yoga Exercise |
Primary outcome
Functional Balance
Time frame: Baseline
Berg Balance Scale : This test is used to quantitatively assess balance in older adults. In this 14-item scale, patients are asked to maintain positions and perform movement tasks of varying degrees of difficulty. Patients receive a score between 0 and 4 on their ability to respond to dimensions of balance. An overall score can be calculated from a total of 56. The higher the score, the better the balance. This scale has been found to be reliable, valid, and is the most commonly used clinical and research scale for assessing balance in stroke patients.
Functional Balance
Time frame: Immediately after the intervention
Berg Balance Scale : This test is used to quantitatively assess balance in older adults. In this 14-item scale, patients are asked to maintain positions and perform movement tasks of varying degrees of difficulty. Patients receive a score between 0 and 4 on their ability to respond to dimensions of balance. An overall score can be calculated from a total of 56. The higher the score, the better the balance. This scale has been found to be reliable, valid, and is the most commonly used clinical and research scale for assessing balance in stroke patients.
Functional Balance
Time frame: 3 months follow-up
Berg Balance Scale : This test is used to quantitatively assess balance in older adults. In this 14-item scale, patients are asked to maintain positions and perform movement tasks of varying degrees of difficulty. Patients receive a score between 0 and 4 on their ability to respond to dimensions of balance. An overall score can be calculated from a total of 56. The higher the score, the better the balance. This scale has been found to be reliable, valid, and is the most commonly used clinical and research scale for assessing balance in stroke patients.
23 secondary outcomes
Functional mobility
Time frame: Baseline
Functional mobility
Time frame: Immediately after the intervention
Functional mobility
Time frame: 3 months follow-up
Gait performance
Time frame: Baseline
Gait performance
Time frame: Immediately after the intervention
Gait performance
Time frame: 3 months follow-up
Maximum isometric muscle strength of the knee extensors
Time frame: Baseline
Maximum isometric muscle strength of the knee extensors
Time frame: Immediately after the intervention
Maximum isometric muscle strength of the knee extensors
Time frame: 3 months follow-up
Activities-specific Balance Confidence Scale - Simplified
Time frame: Baseline
Activities-specific Balance Confidence Scale - Simplified
Time frame: Immediately after the intervention
Activities-specific Balance Confidence Scale - Simplified
Time frame: 3 months follow-up
State Trait Anxiety Inventory
Time frame: Baseline
State Trait Anxiety Inventory
Time frame: Immediately after the intervention
State Trait Anxiety Inventory
Time frame: 3 months follow-up
Beck Depression Inventory
Time frame: Baseline
Beck Depression Inventory
Time frame: Immediately after the intervention
Beck Depression Inventory
Time frame: 3 months follow-up
Reintegration to Normal Living Index
Time frame: Baseline
Reintegration to Normal Living Index
Time frame: Immediately after the intervention
Reintegration to Normal Living Index
Time frame: 3 months follow-up
Compliance during the program
Time frame: During the intervention
Compliance after the program
Time frame: 3 months follow-up
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Mar 2023.
- Background: PubMed 30839270Green E, Huynh A, Broussard L, Zunker B, Matthews J, Hilton CL, Aranha K. Systematic Review of Yoga and Balance: Effect on Adults With Neuromuscular Impairment. Am J Occup Ther. 2019 Jan/Feb;73(1):7301205150p1-7301205150p11. doi: 10.5014/ajot.2019.028944.
- Background: PubMed 28100160Thayabaranathan T, Andrew NE, Immink MA, Hillier S, Stevens P, Stolwyk R, Kilkenny M, Cadilhac DA. Determining the potential benefits of yoga in chronic stroke care: a systematic review and meta-analysis. Top Stroke Rehabil. 2017 May;24(4):279-287. doi: 10.1080/10749357.2016.1277481. Epub 2017 Jan 19.
- Background: PubMed 29164993Edwards MK, Loprinzi PD. Comparative effects of meditation and exercise on physical and psychosocial health outcomes: a review of randomized controlled trials. Postgrad Med. 2018 Mar;130(2):222-228. doi: 10.1080/00325481.2018.1409049. Epub 2017 Nov 27.
- Individual participant dataSharing planned: No. The data collected will be anonymized, computerized and stored by Maxime GILLIAUX. Only the investigators will have access to the anonymized data in order to carry out the statistical work of this research.
Related trials for Chronic Stroke
Active, not recruiting
Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mechanisms for Improving Health of Older Stroke Patients With Multimorbidity
Hypertension, Type 2 Diabetes Mellitus (T2DM)
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
Not yet recruitingObservational study
Detecting and Predicting Post-stroke Cognitive Impairment Using the Oxford Cognitive Screen
Stroke, Ischemic Stroke
Not yet recruiting
Lumbar Spinal Manipulation in Stroke
Stroke
Recruiting
Effect of Lower Limb Proprioceptive Neuromuscular Facilitation Combined With Core Stability Training Versus Proprioceptive Neuromuscular Facilitation Alone on Balance and Functional Mobility in Chronic Stroke Survivors
Stroke
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Maxime Gilliaux, PhD principal investigator
Hôpital La Musse
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Physical activity in people with Chronic Stroke, run by Hopital La Musse at 3 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Functional Balance (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04947293, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2023.